Founding Partner
Medications like Ozempic, Wegovy, Mounjaro, Zepbound, and Trulicity, part of the GLP-1 receptor agonist drug class, have gained popularity for managing diabetes and aiding in weight loss. However, recent guidance from medical bodies and a new FDA warning underscore significant health risks for patients who need surgery while on these drugs. Specifically, GLP-1 medications delay gastric emptying, which can lead to severe complications under anesthesia, such as pulmonary aspiration. This occurs when food or liquid from the stomach is inhaled into the lungs, causing infections, lung damage, or even death. These risks highlight the urgent need for patients, especially those on GLP-1 drugs, to discuss potential complications with healthcare providers before any surgical procedure.
Pulmonary aspiration is a rare but critical risk for patients on GLP-1 drugs undergoing anesthesia. Anesthesia slows down the body’s protective reflexes, making it easier for gastric contents to enter the lungs if the stomach hasn’t fully emptied. Although patients are typically advised to fast before surgery, studies have shown that those on GLP-1 drugs often retain food in their stomachs much longer, increasing the likelihood of aspiration. Cases have emerged where patients, despite fasting for up to 18 hours, experienced severe complications, including respiratory failure requiring intensive care.
This emerging issue has prompted the American Society of Anesthesiologists (ASA) to adjust its guidance on GLP-1 drugs. Initially, the ASA recommended that patients on daily GLP-1 medications pause usage on the day of surgery and that those on weekly injections stop the medication one week before surgery. However, due to ongoing reports of serious complications, some experts now advocate a more extended pause—potentially three weeks—to allow the drug to clear from the body entirely. For individuals who rely on these drugs to manage diabetes or weight, the lack of clear, evidence-backed guidelines adds complexity to their health care, as pausing the medication for an extended period could lead to uncontrolled blood sugar or weight fluctuations.
For patients who have suffered harm due to aspiration or related complications while on GLP-1 medications, pursuing a product liability lawsuit may provide an avenue for holding drug manufacturers accountable. Product liability law allows injured individuals to seek compensation if a product is defectively designed, improperly labeled, or marketed without sufficient warnings of known risks. In the case of GLP-1 medications, the FDA’s recent label update highlights the manufacturers’ awareness of pulmonary aspiration risks linked to these drugs, which can support claims that users were inadequately warned of potential complications.
Victims can take several steps to build a strong case. First, it’s essential to gather evidence such as medical records detailing the injuries sustained, proof of the GLP-1 medication usage, and documentation of adherence to pre-surgical fasting instructions. This information can help demonstrate that the harm was a direct result of the medication’s effects rather than the patient’s actions. Additionally, patients who suffered harm should seek testimony from medical professionals who can confirm the link between GLP-1 drug use and the risk of complications under anesthesia. This evidence is crucial in establishing that the manufacturer’s failure to issue appropriate warnings led to the injury.
The litigation process for product liability cases involves complex legal and medical considerations, making professional legal guidance vital. Attorneys skilled in product liability law can help victims understand their rights, evaluate the strength of their case, and determine the most effective approach. Whether the case proceeds through settlement discussions or a court trial, legal representation ensures that all necessary documentation is gathered, deadlines are met, and the victim’s interests are fully protected. Furthermore, an attorney can effectively argue for various types of compensation, helping victims pursue funds for medical expenses, lost wages, and other damages tied to their injuries.
Injuries from product defects like the aspiration risk associated with GLP-1 drugs can impose severe physical, emotional, and financial burdens on victims. Through a product liability claim, individuals harmed by these drugs may be eligible to recover a range of damages. Medical expenses are often the primary form of compensation, covering costs for hospital stays, surgeries, medications, and ongoing treatment. Victims may also recover damages for lost income if their injuries required an extended recovery period or if they’re unable to return to work due to long-term health issues.
In addition to tangible financial losses, victims of GLP-1-related injuries may seek compensation for pain and suffering. This includes not only the physical discomfort endured but also the emotional distress from dealing with unexpected health setbacks. Some victims may develop anxiety or trauma related to future surgeries or medical procedures, which can profoundly impact their quality of life. In cases where the drug manufacturer is found to have acted with gross negligence or willful disregard for consumer safety, courts may also award punitive damages to penalize the company and deter similar actions in the future.
Pursuing these damages is not just about securing financial relief; it’s also about holding drug manufacturers accountable for failing to provide adequate warnings to consumers. The significant growth in GLP-1 drug prescriptions means that manufacturers must proactively inform users of potential risks. Through legal action, affected individuals can seek justice and help prevent others from suffering similar injuries due to inadequate warnings or guidance.
Parker Waichman LLP
Our law firm is ready to represent you in your injury case. We’ve helped many New York residents as well as those needing help nationwide. Contact our team for a free case consultation today.
I had a great experience with them , everyone was very helpful and sweet.
Michelle Murphy
4 months ago
Zarahi was very professional and very Quick and very knowledgeable i realy appreciated her patience and perseverance she Deserves 100 stars 🌟 but since i can only send 5 i Guess i will just have to send that truly yours Rashine Downs
Kush Three
6 months ago
VERY NICE WORK PLACE THEY HAVE BEEN GOOD TO MY MOM
Whitney Brinson
5 years ago
They treated me with tender love and care
Terrell Weaver
2 months ago
Wonderful people. They made the whole process if dealing with a gov’t agency so easy. Special compliments to Gina Viti
Michael Ross
2 months ago
I’m a 9/11 first responder, and I can honestly say that Parker Waichman made me feel like they had my best interest in my VCF case. Ms Candalino & Ms Viti are top notch in my book. I was constantly informed on the status of my case. I would definitely recommend Parker Waichman LLP to family and friends.
D D
6 years ago
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
Parker Waichman LLP
27299 Riverview Center Boulevard, Suite 108
Bonita Springs, FL 34134
We handle mass torts cases nationwide. Please contact our office to learn more.